Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Obesity is a major risk factor for high blood pressure, so by promoting weight loss, semaglutide often leads to a meaningful drop in blood pressure, including for people whose readings remain high despite taking blood pressure medications
Semaglutide (Ozempic/Wegovy) raises resting heart rate by approximately 14 bpm, and tirzepatide (Mounjaro/Zepbound) by approximately 24 bpm
Novo Nordisks response suggested that those figures did not take into account the resources spent in the years of research and development, stating it spent $10 billion on development of GLP-1 drugs
References 1 ParikhKAntanaviciuteAFawkner-CorbettDJagielowiczMAulicinoALagerholmCet al
L-carnitine supplementation increases trimethylamine-N-oxide but not markers of atherosclerosis in healthy aged women
US$ 26.13
US$ 20.69
US$ 29.10
